SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹213 Cr | ₹200 Cr | ₹178 Cr | ₹55 Cr | ₹41 Cr |
What is the latest Total Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹213 Cr |
| Mar2025 | ₹200 Cr |
| Mar2024 | ₹178 Cr |
| Mar2020 | ₹55 Cr |
| Mar2019 | ₹41 Cr |
How is Total Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹213 Cr | 6.40 | |
| Mar2025 | ₹200 Cr | 12.22 | |
| Mar2024 | ₹178 Cr | 222.38 | |
| Mar2020 | ₹55 Cr | 33.71 | |
| Mar2019 | ₹41 Cr | - | |
Compare Total Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹839.6 Cr | 0.5% | -3.5% | 24.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 0.5% |
-3.5% |
24.8% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses